Skip to main content

Table 1 Demographic information and baseline data of patients with SMA

From: A cross-sectional and longitudinal evaluation of serum creatinine as a biomarker in spinal muscular atrophy

 

Patients with SMA (n = 28)

Age, y, mean (SD)

27.8 (10)

Age of onset, y, mean (SD)

7.81 (9.91)

Course of the disease, y, mean (SD)

19.97 (10.04)

Sex, F/M

11/17

SMA type (2/3/4), n

8/17/3

SMN2 copies (2/3/≥4), n (%)

3/15/10

Motor performance (non-sitter/sitter/ambulant), n

5/8/15

Baseline HFMSE, mean (SD)

31.7 (23.9)

FVC, % (SD)

79.7 (33.9)

Creatinine, umol/L (SD)

23.7 (14.8)